Skip to main content
. Author manuscript; available in PMC: 2007 Mar 20.
Published in final edited form as: Front Neuroendocrinol. 2006 Oct 27;27(4):404–414. doi: 10.1016/j.yfrne.2006.09.003

Table 3.

Summary of Clinical Data on BDNF Expression and Effects of Hormone Replacement Therapy in Specific Neurodegenerative Diseases

Disease BDNF Regulation Ref(s) Hormone Replacement Therapy Ref(s)
Alzheimer’s ↓protein expression [22,34,46,80,89] ↓risk for AD [92,125,146]
Disease ↓mRNA expression [50,87,98] ↑risk for dementia [33,114]
BDNF present in cells surrounding plaques [34] no benefit [86]
Parkinson’s ↓protein expression [54,84,94] ↓risk for PD [24]
Disease ↓in PD symptoms [9,108]
↓in PD symptoms [90]
no benefit [121]
Multiple Sclerosis ↑protein expression w/increased demyelination [63,119] ↑MS symptoms [4,99]
↑mRNA expression [39] ↑risk for MS [128]